[HTML][HTML] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky, K Chow, M Spavor… - Journal of …, 2013 - Elsevier
Background The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

[HTML][HTML] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky… - Journal of …, 2013 - jcmr-online.biomedcentral.com
The late cardiotoxic effects of anthracycline chemotherapy influence morbidity and mortality
in the growing population of childhood cancer survivors. Even with lower anthracycline …

[PDF][PDF] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky, K Chow, M Spavor… - 2013 - core.ac.uk
Background: The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling

EB Tham, MJ Haykowsky, K Chow, M Spavor… - Journal of …, 2013 - go.gale.com
Background The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling

EB Tham, MJ Haykowsky, K Chow… - Journal of …, 2013 - search.proquest.com
Background: The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Diffuse myocardial fibrosis by T-1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling

EB Tham, MJ Haykowsky, K Chow, M Spavor… - Journal of …, 2013 - hero.epa.gov
Background: The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

[PDF][PDF] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky, K Chow, M Spavor… - 2013 - academia.edu
Background: The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

EB Tham, MJ Haykowsky, K Chow… - Journal of …, 2013 - search.ebscohost.com
Background: The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

EB Tham, MJ Haykowsky, K Chow… - … : Official Journal of the …, 2013 - europepmc.org
Background The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …

[HTML][HTML] Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and …

EB Tham, MJ Haykowsky, K Chow, M Spavor… - Journal of …, 2013 - Springer
Background The late cardiotoxic effects of anthracycline chemotherapy influence morbidity
and mortality in the growing population of childhood cancer survivors. Even with lower …